Unit Tokenomics set to replace Unit Economics in HealthTech

Nelson Advisors
12 hours ago
11 min read

The Shift from Unit Economics to Unit Tokenomics in AI-Driven Healthcare Systems

The global digital health sector is undergoing a structural realignment driven by the rapid integration of artificial intelligence, machine learning and large language models (LLMs). For over two decades, the valuation and operational viability of health information technologies were dictated by classic software-as-a-service (SaaS) unit economics. These legacy frameworks relied on highly predictable variables, primarily measured through customer lifetime value (LTV), customer acquisition cost (CAC) and stable, subscription-based licensing models.

However, the emergence of non-deterministic, generative medical architectures has broken these traditional economic frameworks.

The industry is rapidly transitioning toward "Unit Tokenomics", the practice of modelling, tracking and optimising the cost, consumption and business value of computational tokens as the fundamental unit of clinical intelligence and enterprise value.

Within this new paradigm, tokens are not speculative cryptographic assets; instead, they represent the atomic unit of computation, discrete sub-word fragments of clinical text, pixel blocks of radiological images, or frequency bins of physiological audio. Managing the economics of these computational units is now the primary determinant of operating margins and software viability in modern HealthTech.

The Theoretical Transition: Unit Economics vs. Unit Tokenomics

Traditional HealthTech platforms relied on deterministic cloud infrastructures with highly predictable scaling costs. Storage of electronic health records (EHRs), database read-write cycles, and standard network egress fees scale linearly with user adoption. This predictability allowed digital health platforms to maintain high gross margins, typically ranging between 70% and 80%.

Conversely, generative AI workloads scale in highly non-linear, non-deterministic ways. A single patient-provider interaction processed through an ambient clinical intelligence engine does not consume a fixed block of cloud compute. Instead, it triggers probabilistic inferential operations where token consumption varies dynamically based on conversational duration, background noise, clinical vocabulary complexity and the reasoning depth of the selected model.

As a result, AI-driven HealthTech startups frequently operate at significantly depressed gross margins, typically between 40% and 60%, due to escalating variable compute, API, and inference expenses.

Dimension of Comparison	Traditional SaaS Unit Economics	AI Unit Tokenomics
Primary Economic Unit	The User Account / Seat License	The Token (Atomic Computational Unit)
Predictability Model	Deterministic and highly linear	Probabilistic and highly non-deterministic
Average Gross Margin	70% to 80%	40% to 60% (due to unoptimised inference)
Variable Cost Drivers	Static cloud storage, API integrations, host VMs	System prompt size, context window depth, model routing
Orchestration Risk	Extremely low (predictable application logic)	High (retries, multi-agent loops, validation failures)
Value Metric	Cost per seat / Monthly active user (MAU)	Cost per clinical note / Cost per completed workflow

The Rise of TokenOps and the Four Urgent Forces

As artificial intelligence moves from speculative pilot programs to high-volume production, managing token consumption has evolved from a simple engineering concern into a core financial practice. This transition has established "TokenOps". the application of FinOps methodologies specifically to AI token consumption.

While traditional FinOps governs deterministic, variable cost cloud infrastructure like virtual machines and network bandwidth, TokenOps focuses on monitoring, analysing and optimising the variable cost of intelligence computation itself.

The transition to TokenOps is driven by four converging forces that threaten the margins of unprepared HealthTech enterprises. First, AI spend scales at a speed that frequently outpaces organisational budgets. A token spend of $10,000 per month during a clinical pilot can silently compound to $400,000 per month in production as features scale across multiple clinical departments, without any single, centralised decision triggering the increase.

Second, token spend is inherently invisible without specialised instrumentation. Standard foundation model invoices provide bulk token counts and total costs, but contain no metadata regarding which medical feature, patient interaction, or clinical team consumed those resources, turning the monthly bill into an unaccountable black box.

Third, falling per-token market prices often mask exponentially rising consumption. Organisations observing stable monthly AI invoices may mistake flat costs for controlled usage, while in reality, explosive growth in token volume is occurring underneath. Once price declines plateau, this volume growth will surface as severe, unexpected budget pressures.

Fourth, AI introduces a fundamental structural shift in cost behaviour. As agentic capabilities move HealthTech software from per-seat subscription models toward usage-based or outcome-based contracts, finance teams inherit extreme volatility in operating expenses, margins and capital planning.

AI Cost Layer	Metering and Billing Mechanism	Operational and Margin Impact
Foundation Model Inference	Metered in tokens; billed via API or self-hosted derived cost.	Direct operational floor; highly variable based on clinical usage.
Cloud Compute & Storage	Billed per GPU/TPU/accelerator hour and vector database storage.	Driven by continuous model training, clinical index generation, and RAG pipelines.
Data Center Infrastructure	Capital cost of facilities, physical power, cooling, and networking.	High upfront capex; next-gen facilities cost $15M to $20M per megawatt of capacity.
Networking & Egress	Inter-region data movement and multi-cloud routing fees.	Often underestimated in multi-agent clinical architectures.
SaaS Feature Embedding	Structured per-seat, per-workflow, or per-outcome fees.	Abstracts token costs from users; costs typically drift upward during renewals.
Engineering & MLOps	Salaries, observability tooling, evaluation pipelines, and security audits.	High fixed overhead required to maintain clinical safety and compliance.
Data Acquisition & Licensing	Licensing fees for training corpora and historical clinical registries.	Critical for domain-specific medical model development and fine-tuning.

Token Heterogeneity, Goodput and the Pareto Frontier

An operational analysis of AI consumption that treats all tokens as homogeneous is fundamentally flawed. Token economics must account for the reality of token heterogeneity, which dictates that tokens delivered at different speeds, latencies, and reasoning capacities represent completely different economic assets.

This relationship is defined by the Pareto frontier of AI performance, which balances accuracy, speed (tokens per second), and financial cost. For instance, a token processed at five tokens per second on a large, highly synchronised reasoning model is a vastly different economic and clinical asset than a token generated at five hundred tokens per second on a distilled, edge-deployed classifier.

To align computational consumption with business value, TokenOps practitioners must distinguish between raw "Tokenomics" and "AI Unit Economics". Tokenomics tracks the technical metrics of token cost, usage, and efficiency. AI Unit Economics evaluates whether that consumption creates measurable business value at the workflow or clinical outcome level.

For example, a cheaper model may cost less per token but require five sequential correction attempts to generate an accurate patient discharge summary, resulting in a low token yield rate and high latencies. Conversely, a premium model might cost significantly more per token but complete the task accurately in a single step. Thus, focusing solely on the raw cost per token is insufficient; organisations must connect token consumption to broader clinical outcomes and operating margins.

Applied Microeconomics in Clinical Ambient Intelligence

The operational dynamics of unit tokenomics are highly visible in the ambient clinical scribing market. In this vertical, digital scribes (such as Nabla, Abridge, Heidi Health, and DeepCura) leverage automatic speech recognition and LLMs to transcribe patient-provider conversations and draft structured medical documentation, directly replacing traditional dictation methods. Modern speech engines have achieved clinical-grade accuracy, with word error rates falling as low as 2.3%. However, the economic viability of these platforms depends heavily on managing the underlying token flows.

The primary metric in this domain is the "cost per clinical note". Consider a pediatrician who conducts 30 patient consultations per day over 22 working days per month. The resulting conversational transcript yields an average of 4,000 words, which translates to approximately 5,461 tokens based on standard tokenisation rates where roughly 1,500 English words equal 2,048 tokens. To process this conversation, the application appends a comprehensive, 2,000-token system prompt containing clinical guidelines and structured formatting templates, resulting in a total of 7,461 input tokens. The model then generates an 800-word structured clinical note, equivalent to roughly 1,092 output tokens.

At first glance, an inference cost of approximately $0.05 per note appears negligible. However, if the platform bills the clinician a flat rate of $24.99 per month, the economic sustainability of the user is highly sensitive to clinical volume and system usage. For a high-volume paediatrician conducting 660 consultations per month, the total raw model inference cost is $35.44. When factoring in voice-to-text processing, vector databases, EHR integration APIs, logging, validation loops and engineering overhead, the actual cost-to-serve easily surpasses the flat subscription price, resulting in negative unit margins.

This subscription billing dilemma highlights a key structural challenge: charging a low, flat fee across all users forces the platform to burn capital on heavy users, while high flat fees overcharge the estimated 70% of clinicians who do not consume high volumes of inference compute. This requires the design of highly optimized, two-tiered or usage-based pricing models.

Optimisation Technique	Core Engineering Mechanism	Blended Cost Reduction	Clinical Performance Impact
Dynamic Model Routing	Lightweight classifiers route routine clinical tasks to smaller models, escalating to frontier models only for complex reasoning.	Up to 60% cost savings	Maintains high clinical accuracy while optimizing speed.
Context & RAG Engineering	Truncates conversational histories, compresses system prompts, and injects only high-scoring vector database passages.	10% - 20% per-call savings; 30% - 60% input reduction	Improves reasoning clarity by eliminating redundant context.
Semantic Response Caching	Stores and instantly reuses pre-approved responses for repetitive clinical queries or administrative tasks.	10% - 30% token savings	Eliminates latency and enforces consistency on critical answers.
Hybrid Logic Architecture	Uses deterministic, procedural code for calculations and validations, reserving LLMs for unstructured reasoning.	15% - 25% inference savings	Eliminates mathematical hallucinations and logic errors.
Targeted Fine-Tuning	Fine-tunes smaller, open-source models on proprietary clinical datasets after proving success with general models.	Up to 90% inference cost reduction	Replicates or exceeds the clinical accuracy of frontier models for specific tasks.

Decentralised Infrastructure and the Web3 Health Token Economy

As medical research and clinical AI models scale, they require massive datasets and computational infrastructure. However, traditional health data systems are highly fragmented, locked within institutional silos, and subject to severe regulatory barriers.

Furthermore, traditional data brokers often commercialise de-identified patient data without direct patient consent or equitable compensation. To resolve these structural failures, Decentralised Science (DeSci) and Decentralised Physical Infrastructure Networks (DePIN) are introducing token economic frameworks to secure patient privacy, reward data contributors, and establish clear data provenance.

This emerging Web3 health token economy is governed by specialized blockchain networks. According to Messari's State of DePIN 2025, the DePIN sector represents roughly $10Bn in circulating market cap and $72M in on-chain revenue, with leading networks trading at 10 to 25 times revenue multiples. Unlike purely software-native networks, physical infrastructure networks must navigate real-world constraints, such as physical hardware costs, geographic coverage requirements and slow response to price shocks.

DePIN tokenomics coordinates these two-sided markets, utilising token incentives to reward independent hardware operators (supply) for providing storage, compute, or sensor resources to enterprise users (demand).

DePIN Token Role	Core Economic & Cryptographic Mechanism	Operational Healthcare Impact
Incentivize Supply	Distributes inflationary token emissions to hardware operators for deploying compute nodes.	Lowers infrastructure barriers for clinical AI workloads.
Coordinate Governance	Grants token holders voting rights over network fee structures and resource allocation.	Prevents centralized capture of sovereign clinical data registries.
Function as Payment	Serves as the native currency for accessing resources, activating services, and purchasing data.	Simplifies cross-border billing and automates multi-party clinical revenue shares.
Secure the Network	Requires nodes to stake tokens as collateral, which are slashed if they submit malicious or inaccurate data.	Prevents adversarial cheating, data corruption, and unauthorised data breaches.

When designed effectively, this token economy generates a self-reinforcing flywheel. Early token emissions attract hardware contributors, expanding physical network capacity and improving service quality. This improved infrastructure attracts real demand from research institutions and hospitals, driving organic utility and transaction volume.

Over time, this organic demand sustains the token's value, allowing networks like Helium and io.net to provide up to 70% cost savings compared to legacy, centralised cloud providers. To ensure the stability of these complex networks, tokenomics experts utilise tools such as agent-based modelling and game theory to conduct rigorous audits, ensuring that honest network contribution remains far more profitable than attempting to game the verification system.

Cryptographic Architectures for Sovereign Data and Precision Medicine

The execution of precision medicine, drug discovery, and cross-institutional clinical analytics requires access to sensitive patient records, such as electronic health records (EHRs) and genomic sequences. To protect this information, modern HealthTech architectures are integrating advanced cryptographic primitives, specifically hardware-level secure virtualisation and Fully Homomorphic Encryption (FHE).

FHE represents a massive security breakthrough, allowing complex mathematical computations to be performed directly on encrypted data (ciphertext) without ever decrypting it. Most FHE constructions are built on lattice-based cryptography, utilising the mathematical hardness of Learning with Errors (LWE) and Ring Learning with Errors (RLWE) problems.

Because each homomorphic operation introduces a small amount of mathematical noise, FHE systems utilise a specialised technique called "bootstrapping" to periodically refresh the ciphertext and reduce accumulated noise, enabling unlimited, complex calculations.

An authoritative report by the European Union Agency for Cybersecurity (ENISA) notes that while FHE provides exceptional data protection, it historically introduced significant performance overhead. However, this overhead has dropped by multiple orders of magnitude over the past decade, making FHE increasingly viable for enterprise medical workloads.

From a regulatory perspective, FHE simplifies compliance with strict data protection laws like HIPAA and the EU's GDPR. Under GDPR Article 32 (Security of Processing), FHE serves as an advanced pseudonymisation measure that dramatically reduces data breach liability.

Similarly, deep legal analysis suggests that if Protected Health Information (PHI) is encrypted using FHE and the decryption key remains solely with the covered clinical entity, the processed data can be treated as de-identified outside the scope of HIPAA, enabling secure, outsourced analytics. This capability is highlighted in reports by the American Health Information Management Association (AHIMA), which emphasise FHE's promise for cross-institutional clinical data collaboration.

               [ User Data Owner ]
                       |
        1. Generates Keypair (Public, Private, Evaluation)
        2. Encrypts Genomic Data -> Ciphertext
                       |
                       v
         [ Secure AMD SEV-ES DNA Vault ]
                       |
        3. Researcher Queries Vault via Smart Contract
        4. FHE Engine Computes on Ciphertext (LWE/RLWE Problems)
        5. Performs Bootstrapping to Manage Noise
                       |
                       v
         [ Encrypted Computational Result ]
                       |
        6. Transferred to User Decryption App
        7. Decrypted with Private Key -> Actionable Answer

This cryptographic paradigm is actively utilised by several decentralised healthcare protocols:

Genomes.io (GENOME)

Traditional DNA sequencing platforms often analyze only 0.02% of the genome and monetize their databases by selling ownership of user data to third-party pharmaceutical companies. Genomes.io addresses this issue by providing clinical-grade, 30x whole genome sequencing (100% analysis), giving users full ownership of their entire genetic profile.

The genomic data is stored in secure, hardware-level AMD SEV-ES encrypted "DNA Vaults". The Ethereum blockchain is used to maintain an immutable, transparent audit trail of all access events.

Through a mobile application, users receive and approve specific queries from researchers. When a query is approved, only the specific answer to the researcher's question is released, allowing users to earn GENOME tokens while keeping their raw genetic data completely private.

Strategic Industry Outlook

The transition from SaaS unit economics to unit tokenomics represents a permanent shift in how HealthTech platforms are built, valued, and operated. General-purpose software licensing models are no longer sufficient to manage the variable, non-deterministic cost of modern medical AI.

To protect operating margins, HealthTech enterprises must implement dedicated TokenOps practices, utilising model routing, semantic caching, and targeted fine-tuning to control inference costs.

Simultaneously, the integration of DePIN and advanced cryptographic primitives like Fully Homomorphic Encryption is establishing secure, decentralised data markets. These systems allow researchers to query sensitive clinical and genomic records without compromising patient privacy or violating strict global compliance standards.

Ultimately, the HealthTech organisations that master these token-level economics and cryptographic architectures will lead the next generation of clinical workflow automation, sovereign medical data management and pharmaceutical discovery.

Nelson Advisors > European MedTech and HealthTech Investment Banking

Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital

Nelson Advisors publish Europe’s leading HealthTech and MedTech M&A Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech